V CompBrief BY VELARION

Executive Vice President, Chief Financial Officer · CYTOKINETICS INC (CYTK)

Sung Lee

A named executive officer of CYTOKINETICS in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$3,770,807

FY2024: $5,918,931

5th of 5 named executive officers at Cytokinetics by FY2025 total.

5 named officers on file for CYTOKINETICS, FY2025

See an example →

What this number hides

The filing gives the total. CYTOKINETICS’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how CYTOKINETICS’s whole pay program stands against its peers

  • CYTOKINETICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CYTK→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 17, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-10.

Free

Get Sung Lee’s full pay file as a PDF — free

More than this page: up to 10 years of Sung’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Sung Lee and every company like it: Velarion Intel, free for 3 days, no card →

Sung Lee compensation by year

CYTOKINETICS Summary Compensation Table · all 2 fiscal years held
In US dollars, as CYTOKINETICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$550,000$572,918
Bonus$80,000$0
Stock awards$3,352,526$1,449,995
Option awards$1,752,473$1,434,764
Non-equity incentive$177,522$295,608
Pension and deferred compensation—$0
All other$86,410$17,522
Total$5,918,931$3,770,807

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CYTOKINETICS INC DEF 14A filed April 17, 2026, accession 0001140361-26-015364, and prior-year filings.

How this page was built: the CYTOKINETICS INC filed document, accession 0001140361-26-015364. Every figure is read from that document and cited to the page and table it appears in. Filed April 17, 2026.

$5.9M
$3.8M
FY24
FY25
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU32,687$2,076,932—
RSU20,810$1,322,267—
PSU2,152$136,706—
Option39,404—$44.36
Option32,273—$48.51

Per the Outstanding Equity Awards at Fiscal Year-End table in CYTOKINETICS INC's FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

30 Form 4 lines since the FY2025 proxy (filed April 17, 2026)
current to 2026-11-10 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-07-01Sale10b5-11,112$87.7963,221
2026-07-01Exercise or conversion10b5-11,112$48.5164,333
2026-07-01Exercise or conversion derivative10b5-11,112$0.0026,709
2026-06-29Exercise or conversion10b5-1188$44.3663,409
2026-06-29Exercise or conversion derivative10b5-1822$0.0040,504
2026-06-29Exercise or conversion derivative10b5-1823$0.0039,681
2026-06-29Exercise or conversion derivative10b5-1188$0.008,828
2026-06-29Exercise or conversion10b5-1823$44.3666,355

The 8 most recent of 30 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

CYTOKINETICS’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Robert BlumPresident and Chief Executive Officer$11,881,456
Jeffrey HessekielExecutive Vice President, Chief Legal and Administrative Officer$6,086,217
Fady MalikExecutive Vice President, Research and Development$4,467,066
Andrew CallosExecutive Vice President, Chief Commercial Officer$3,787,644
Sung Lee · this pageExecutive Vice President, Chief Financial Officer$3,770,807

Sung Lee's compensation dossier, CYTOKINETICS

You have read Sung Lee's totals and holdings. The dossier adds each equity grant CYTOKINETICS disclosed for Sung Lee and CYTOKINETICS's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full CYTOKINETICS compensation record

free company brief
CYTOKINETICS INC (CYTK) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within CYTOKINETICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the CYTOKINETICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order CYTOKINETICS's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosures
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CYTOKINETICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Sung Lee's compensation dossier